Check if trademark BELVIQ is available

USPTO Filing History

Key events recorded for this trademark application

2012-08-27 — Application filed
2012-08-30 — Application filed
2012-09-05 — Application filed
2012-09-06 — Notice of design search code mailed
2012-10-12 — Approved for pub - principal register
2012-10-12 — Assigned to examiner
2012-10-31 — Notice of publication
2012-11-20 — Published for opposition
2013-01-15 — Noa mailed - sou required from applicant
2013-07-15 — Teas statement of use received
2013-07-15 — Use amendment filed
2013-07-15 — Teas change of correspondence received
2013-08-02 — Case assigned to intent to use paralegal
2013-08-11 — Statement of use processing complete
2013-08-23 — Allowed principal register - sou accepted
2013-09-03 — Assigned to lie
2013-09-04 — Law office registration review completed
2013-09-05 — Notice of acceptance of statement of use e-mailed
2013-10-08 — Registered-principal register
2017-01-31 — Correspondence received in law office
2017-04-05 — Review of correspondence complete - address updated
2017-08-07 — Attorney/dom.rep.revoked and/or appointed
2017-08-07 — Teas revoke/app/change addr of atty/dom rep received
2017-08-09 — Automatic update of assignment of ownership
2018-10-08 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2019-10-04 — Teas section 8 & 15 received
2019-11-12 — Case assigned to post registration paralegal
2019-11-13 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
2019-11-13 — Notice of acceptance of sec. 8 & 15 - e-mailed
2022-10-08 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
2024-04-19 — Cancelled sec. 8 (10-yr)/expired section 9
2024-04-19 — Final status recorded

Owner Information

EISAI INC.
Andover , MA

Arena Pharmaceuticals GmbH
CH-4800 Zofingen CH

Correspondent

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd Street, 17th Floor
New York, NY 10036
UNITED STATES

Filing Details

Filing Date:
2012-08-27

Status Date:
2024-04-19

Category:
Pharmaceuticals

Filing Year:
2011